JGC
J. Goldman & Co’s Rigel Pharmaceuticals RIGL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-29,839
| Closed | -$32.2K | – | 328 |
|
|
2023
Q3 | $32.2K | Hold |
29,839
| – | – | ﹤0.01% | 218 |
|
|
2023
Q2 | $38.5K | Hold |
29,839
| – | – | ﹤0.01% | 228 |
|
|
2023
Q1 | $39.4K | Hold |
29,839
| – | – | ﹤0.01% | 231 |
|
|
2022
Q4 | $44.8K | Hold |
29,839
| – | – | ﹤0.01% | 248 |
|
|
2022
Q3 | $35K | Sell |
29,839
-135,000
| -82% | -$158K | ﹤0.01% | 249 |
|
|
2022
Q2 | $186K | Sell |
164,839
-365,066
| -69% | -$412K | 0.01% | 214 |
|
|
2022
Q1 | $1.58M | Buy |
529,905
+338,066
| +176% | +$1.01M | 0.07% | 147 |
|
|
2021
Q4 | $508K | Buy |
191,839
+121,500
| +173% | +$322K | 0.03% | 214 |
|
|
2021
Q3 | $255K | Sell |
70,339
-248,117
| -78% | -$899K | 0.01% | 231 |
|
|
2021
Q2 | $1.38M | Buy |
318,456
+270,227
| +560% | +$1.17M | 0.05% | 209 |
|
|
2021
Q1 | $165K | Sell |
48,229
-52,810
| -52% | -$181K | 0.01% | 312 |
|
|
2020
Q4 | $354K | Sell |
101,039
-741,447
| -88% | -$2.6M | 0.02% | 232 |
|
|
2020
Q3 | $2.02M | Sell |
842,486
-184,560
| -18% | -$443K | 0.14% | 124 |
|
|
2020
Q2 | $1.88M | Buy |
1,027,046
+734,047
| +251% | +$1.34M | 0.12% | 127 |
|
|
2020
Q1 | $457K | Buy |
+292,999
| New | +$457K | 0.06% | 134 |
|
|
2018
Q2 | – | Sell |
-832,500
| Closed | -$2.95M | – | 310 |
|
|
2018
Q1 | $2.95M | Sell |
832,500
-154,500
| -16% | -$547K | 0.13% | 113 |
|
|
2017
Q4 | $3.83M | Buy |
987,000
+52,000
| +6% | +$202K | 0.2% | 74 |
|
|
2017
Q3 | $2.38M | Buy |
935,000
+337,000
| +56% | +$856K | 0.12% | 104 |
|
|
2017
Q2 | $1.63M | Buy |
598,000
+104,000
| +21% | +$284K | 0.09% | 115 |
|
|
2017
Q1 | $1.64M | Sell |
494,000
-287,000
| -37% | -$950K | 0.08% | 126 |
|
|
2016
Q4 | $1.86M | Buy |
781,000
+419,971
| +116% | +$1,000K | 0.12% | 101 |
|
|
2016
Q3 | $1.33M | Sell |
361,029
-368,171
| -50% | -$1.35M | 0.07% | 127 |
|
|
2016
Q2 | $1.63M | Buy |
729,200
+315,411
| +76% | +$703K | 0.08% | 116 |
|
|
2016
Q1 | $861K | Buy |
+413,789
| New | +$861K | 0.05% | 147 |
|